Atlas Trials

A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP

Clinical trial NCT04039477 · WITHDRAWN

Trial details

NCT number
NCT04039477
Sponsor
Kezar Life Sciences, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Autoimmune Hemolytic AnemiaImmune Thrombocytopenia
Start date
2020-07-01
Primary completion
2020-08-05
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.